Risperidone
Brand name: Risperdal
124 NDCs across 19 manufacturers|103 Generic,21 Brand
Risperidone, formerly Risperdal, is an atypical antipsychotic approved for schizophrenia, bipolar mania, and irritability associated with autism. Oral tablets, dissolving tablets, and solution are all long-genericized and inexpensive. The long-acting injectables built on the same molecule (Risperdal Consta, Perseris) remain costly brand products and are priced per syringe/kit rather than per tablet.
▸ More about this market▾ Less
Risperidone is used to treat autistic disorder, bipolar disorder, dementia, schizophrenia and tourette syndrome, per the National Library of Medicine's MED-RT classification. The brand product was first FDA-approved on Dec 29, 1993, and the first generic was approved Jun 30, 2008. FDA's Orange Book lists 120 AB-rated (therapeutically equivalent) products for this ingredient. In 2024, Medicare Part D spent $179 million on Risperidone across 3.8 million claims for 496,000 beneficiaries.
Risperidone is available as 124 NDCs from 19 manufacturers (103 generic, 21 brand), with NADAC prices from $0.04 to $2764.70 per EA — the most expensive product costs about 76,184× the cheapest. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
124
103G / 21B
Manufacturers
19
competing in market
Price Spread
$0.04 – $2764.70
per EA, 112 of 124 NDCs
7d Activity
avg +2.8% WoW · of 124 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Explore this market from other angles
Move from the molecule page into the supplier, class, and trend views that create the strongest internal-link cluster for this market.
Top supplier
Janssen Pharmaceuticals Inc. manufacturer profile
Open the supplier page for the manufacturer with the strongest footprint in this market.
Lead class
Atypical Antipsychotic class view
See how this market rolls up into the broader therapeutic class and compare other drugs in the same bucket.
Trend hub
Latest market trends
Move from this single molecule into the current cross-market mover and volatility view.
Guide
How to interpret NADAC
Review the benchmark methodology behind the prices and spreads shown on this market page.
Manufacturer Breakdown
19 manufacturers producing RISPERIDONE(4 pricing outliers)
Frequently Asked Questions
What is Risperidone used to treat?
Risperidone is used to treat autistic disorder, bipolar disorder, dementia, schizophrenia and tourette syndrome, per the National Library of Medicine's MED-RT classification.
When did Risperidone become available as a generic?
FDA approved the first generic Risperidone (ANDA) on Jun 30, 2008. The Orange Book currently lists 120 AB-rated products for this ingredient, meaning FDA considers them therapeutically equivalent to the brand.
How much does Medicare spend on Risperidone?
In 2024, Medicare Part D spent $179 million on Risperidone across 3.8 million claims for 496,000 beneficiaries.
How many Risperidone products are on the market?
The Risperidone drug market contains 124 NDCs from 19 manufacturers — 103 generic and 21 brand products.
What is the price range for Risperidone?
NADAC reference prices for Risperidone range from $0.0363 to $2764.7050 per EA — the most expensive product costs about 76,184× the cheapest. 12 additional products are priced per different units (e.g. liquids per ML) and aren't directly comparable.
Is generic Risperidone cheaper than brand?
The average generic NADAC for Risperidone is $34.8964 per EA, versus $539.4613 for brand-labeled products — brand versions average about 15× the generic price.
Which manufacturers make Risperidone?
19 manufacturers list Risperidone in NADAC. Ranked by number of NDCs, the largest are Janssen Pharmaceuticals Inc. (14), Solco Healthcare US LLC (12), Ajanta Pharma USA Inc. (12), Torrent Pharmaceuticals Limited (12), Zydus Pharmaceuticals (USA) Inc. (12).
How has the price of Risperidone changed recently?
Over the past 7 days, 82 Risperidone NDCs rose and 32 fell, with a market-wide average change of +2.8%.